0

XRP44X

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP729605214-B
CAS729605-21-4
MDL NumberMFCD12828749
Molecular Weight380.87
InChI KeyNPHPNBGYPKBDDB-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: ≥20 mg/mL
Assay≥98% (HPLC)
Colorwhite to off-white
Formpowder
Size5MG, 25MG
Storage Conditionsroom temp
1

c-Jun N-terminal Kinase Mediates Microtubule-Depolymerizing Agent-Induced Microtubule Depolymerization and G2/M Arrest in MCF-7 Breast Cancer Cells

Juan Chen, Wei-Liang Sun, Bohdan Wasylyk, Yan-Ping Wang, Hong Zheng

Anticancer Drugs. 2012 Jan;23(1):98-107.

PMID: 21968419

1

Inhibition of the Ras-Net (Elk-3) Pathway by a Novel Pyrazole That Affects Microtubules

Christine Wasylyk, Hong Zheng, Christelle Castell, Laurent Debussche, Marie-Christine Multon, Bohdan Wasylyk

Cancer Res. 2008 Mar 1;68(5):1275-83.

PMID: 18316589

1

XRP44X Enhances the Cytotoxic Activity of Natural Killer Cells by Activating the c-JUN N-Terminal Kinase Signaling Pathway

Kwang-Soo Kim, Kyung-Soon Park

Dev Reprod. 2020 Mar;24(1):53-62.

PMID: 32411918

1

XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice

Kostyantyn Semenchenko, Christine Wasylyk, Henry Cheung, Yves Tourrette, Peter Maas, Jack A Schalken, Gabri van der Pluijm, Bohdan Wasylyk

PLoS One. 2016 Jul 18;11(7):e0159531.

PMID: 27427904

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode